Brand-name vs compounded
Hers vs Mochi Health: Brand-Name or Compounded? (2026)
Hers $149/mo, Mochi Health $99/mo. What each 2026 program includes, what it omits, and which patient each one suits.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.8 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Hers versus Mochi Health is a common shortlist, and it is a more interesting one than the two homepages suggest.
Hers dispenses brand-name, FDA-approved finished medication. Mochi Health dispenses compounded medication prepared by a pharmacy rather than manufactured under an approved application. Those are different regulatory categories, and the price difference between them is the whole reason both business models exist.
Each program is read on its own published terms first, then against the other on the four things that decide satisfaction: price, predictability, formulary and access to a clinician. No number here is inferred; if a provider does not publish it, the table says so.
The short answer
- Lowest ongoing rate
- Mochi Health — $99/mo against $149/mo, though only one of the two publishes enough to total a full year.
- FDA-approved medication
- Hers — FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen — a finished product the FDA has reviewed, rather than a compounded preparation.
- Least friction to get going
- Hers — Online intake with clinician review, then home delivery, no insurance required.
- Widest medication choice
- Hers — FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen.
Hers vs Mochi Health: the specification
Scan the pricing rows first, then the medication row. Those two settle most of these decisions between them.
| Hers | Mochi Health | |
|---|---|---|
| Advertised price | Wegovy pill from $149/mo, injectable from $199/mo | Membership plus medication from $99/mo, 50% off the first month |
| Rate after promotions | $149/mo | $99/mo |
| Pricing structure | Published rate per medication | Membership fee plus the cost of medication |
| Medication | FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen | Compounded GLP-1 |
| Support model | Provider check-ins included | Provider check-ins included |
| Shipping | Home delivery, no insurance required | Home delivery |
| Price transparency | Published upfront | Partly published |
| Tirzepatide | Not published | Not published |
| Patient reviews | 6,200 | 36,124 |
| eRxDoctor score | 9.8/10 | 7.0/10 |
Hers vs Mochi Health on total cost, not entry price
Both providers lead with a number designed to get you through the intake. Below, both are carried out to six and twelve months so the comparison holds at the point it matters.
| Hers | Mochi Health | |
|---|---|---|
| First month | $149 | $99 |
| Months 2 onward | $149/mo | Not published |
| 6-month total | $894 | Not computable |
| 12-month total | $1,788 | Not computable |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Mochi Health: total monthly cost is membership plus medication and varies by plan and medication. Treat any comparison that quotes one as an estimate someone else has made for you.
Approved medication or compounded preparation
Hers supplies FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen. A brand-name GLP-1 is a finished drug the FDA has reviewed for safety, efficacy and manufacturing quality, and every vial or pen is the same product made to the same specification.
Mochi Health supplies compounded GLP-1 — compounded medication prepared by a pharmacy rather than manufactured under an approved application. That is what makes $99/mo possible in the first place, and it is also why the oversight is not the same.
The honest framing is a trade, not a ranking. Compounded access is what has put GLP-1 treatment within reach of people whose insurance will not cover it; approved product is what removes a category of uncertainty about what is in the vial. Both of those are real.
Hers: what you are buying
Hers offers FDA-approved Wegovy® (brand-name semaglutide) with a personalized care team and ongoing dose check-ins, no compounded medications. What it is really selling here is brand-name Wegovy at a price that usually buys compounded medication elsewhere.
Getting started means online intake with clinician review, after which home delivery, no insurance required. Pricing runs on a published rate per medication basis, published upfront.
Personalized care team with ongoing dose check-ins. The formulary covers FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen.
Hers pros
- No insurance required
- FDA-approved brand-name Wegovy®, not a compounded product
- Personalized care team with ongoing dose check-ins
Hers cons
- No compounded/generic alternative offered
- Higher starting price than most compounded competitors
Against Mochi Health specifically, the trade you are making: there is no compounded tier to fall back on if the brand-name price stops working for you.
How Mochi Health works
50% Off Your 1st Month with Code BESTWLHALFOFF Against Hers, that puts it in the position of the cheaper option.
The process is live video visit with a doctor, bookable in about 5 minutes, then home delivery. On money, expect membership fee plus the cost of medication — partly published.
Support: 24/7 support plus ongoing appointments throughout the program. The medications on offer are compounded GLP-1.
Mochi Health pros
- Membership-plus-medication pricing starts as low as $99/month
- 24/7 support plus ongoing appointment availability throughout your program
- Reliable GLP-1 prescription access in all 50 states
- 50% off your first month with code BESTWLHALFOFF
Mochi Health cons
- Compounded medication focus, branded options not the primary offering
- Pricing is membership plus medication, so total monthly cost varies by plan and medication
- Ongoing pricing is less transparent than flat-rate competitors
Set beside Hers, the thing to weigh: membership-plus-medication pricing is harder to forecast than a flat rate.
Picking between them
Choose Hers if:
- you want an FDA-approved finished medication rather than a compounded preparation
- you want the full price in front of you before completing an intake
- you want a single monthly charge rather than a membership plus medication
- what it leads on is worth paying for in your case: brand-name Wegovy at a price that usually buys compounded medication elsewhere
Choose Mochi Health if:
- you want to start on their timeline: live video visit with a doctor, bookable in about 5 minutes
- the level of clinical contact suits you: 24/7 support plus ongoing appointments throughout the program
- delivery works the way you want it to: home delivery
- you would rather use the platform with the longer public record (36,124 reviews)
What each one gives up
On price. $99/mo against $149/mo. Hers is asking you to pay for brand-name Wegovy at a price that usually buys compounded medication elsewhere; decide whether that is a line item you will use.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On access. Hers advertises online intake with clinician review and home delivery, no insurance required; Mochi Health advertises live video visit with a doctor, bookable in about 5 minutes and home delivery. Coverage differs too — not published against all 50 states — which decides the question before price does if you are in a restricted state.
On predictability. Published rate per medication versus membership fee plus the cost of medication. Whichever you pick, get the maintenance-dose price in writing at intake.
The clinical evidence, separated from the marketing
Neither Hers nor Mochi Health manufactures the molecule it prescribes, and the clinical evidence behind GLP-1 treatment belongs to the drug rather than to any platform selling access to it.
Weight regain after withdrawal is the documented pattern: the STEP 1 extension recorded participants returning to close to their starting weight a year after stopping, per Diabetes, Obesity and Metabolism.
STEP 1 recorded a mean 14.9% reduction in body weight over 68 weeks on weekly semaglutide, against 2.4% for placebo, per NEJM, STEP 1.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
Hers vs Mochi Health: common questions
What happens when Mochi Health's promotional price ends?
Total monthly cost is membership plus medication and varies by plan and medication. Ask for it before the first charge, since it governs almost the entire cost of a year of treatment.
Which has more patient reviews, Hers or Mochi Health?
Mochi Health, with 36,124 against 6,200. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
How fast can I start with Hers compared with Mochi Health?
Hers advertises online intake with clinician review, with home delivery, no insurance required. Mochi Health advertises live video visit with a doctor, bookable in about 5 minutes, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Do Hers or Mochi Health take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
What happens if I stop taking the medication?
Both programs are month to month, which makes stopping easy and makes the consequence of stopping the thing to plan for: published extension data shows most of the lost weight returns within about a year. That is an argument for choosing on annual cost rather than entry price.
The verdict
Mochi Health is the cheaper of the two to run at $99/mo, but a full-year total is only computable for one side of this comparison, so treat that as a directional finding rather than a settled one.
Hers's case is brand-name Wegovy at a price that usually buys compounded medication elsewhere; its cost: there is no compounded tier to fall back on if the brand-name price stops working for you.
The failure mode here is not picking the wrong platform; it is stopping treatment because the bill moved. Choose the one whose bill you can predict.
Keep comparing
- Hers vs TrimRxBrand-name vs compounded
- Shed vs HersPublished price vs quote-only
- MedVi vs Mochi HealthBudget vs premium
- JoinFridays vs Mochi HealthBudget vs premium
- Ro.co vs LIV BodyBrand-name vs compounded
- Ro.co vs NoviBrand-name vs compounded
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Hers or Mochi Health, and does not sell treatment. Read our ranking methodology.